Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities: 2014-2024

Historic Total Non-Current Liabilities for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to $824.2 million.

  • Amphastar Pharmaceuticals' Total Non-Current Liabilities rose 8.82% to $860.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $860.2 million, marking a year-over-year increase of 8.82%. This contributed to the annual value of $824.2 million for FY2024, which is 3.12% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Total Non-Current Liabilities stood at $824.2 million for FY2024, which was down 3.12% from $850.8 million recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Total Non-Current Liabilities peaked at $850.8 million during FY2023, and registered a low of $169.3 million during FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Total Non-Current Liabilities had a median value of $824.2 million in 2024 and averaged $624.6 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Total Non-Current Liabilities fell by 5.51% in 2022, and later soared by 328.03% in 2023.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Total Non-Current Liabilities stood at $169.3 million in 2020, then grew by 24.25% to $210.4 million in 2021, then dropped by 5.51% to $198.8 million in 2022, then surged by 328.03% to $850.8 million in 2023, then decreased by 3.12% to $824.2 million in 2024.